Eligibility for vericiguat in a real‐world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry

Aim We investigated the eligibility for vericiguat in a real‐world heart failure (HF) population based on trial, guideline and label criteria. Methods and results From the Swedish HF registry, 23 573 patients with HF with reduced ejection fraction (HFrEF) enrolled between 2000 and 2018, with a HF du...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of heart failure 2023-08, Vol.25 (8), p.1418-1428
Hauptverfasser:	Nguyen, Ngoc V., Lindberg, Felix, Benson, Lina, Ferrannini, Giulia, Imbalzano, Egidio, Mol, Peter G.M., Dahlström, Ulf, Rosano, Giuseppe M.C., Ezekowitz, Justin, Butler, Javed, Lund, Lars H., Savarese, Gianluigi
Format:	Artikel
Sprache:	eng
Schlagworte:	Eligibility Guidelines Heart failure Label Randomized controlled trial Vericiguat
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!